Announced
Completed
Financials
Sources
Tags
United States
Completed
Acquisition
Friendly
biotechnology company
Majority
Single Bidder
Private Equity
genetic analysis
Biotechnology
Private
Synopsis
Insight Partners-backed GraphPad, a provider of data analysis and visualization software for the life sciences industry, completed the acquisition of Biomatters, a provider of Geneious DNA data analysis solutions. Financial terms were not disclosed. "The acquisition of Biomatters is an exciting opportunity to better serve our customers and the scientific community. There is a critical need for scientists and researchers to leverage technology in a way that enhances—not impedes—innovation. As a unified company, we can invest further in these software solutions allowing scientists to stay focused on advancing their research," Thomas Swalla, GraphPad CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.